CARECONNECT4ME Trademark

Trademark Overview


On Monday, September 16, 2024, a trademark application was filed for CARECONNECT4ME with the United States Patent and Trademark Office. The USPTO has given the CARECONNECT4ME trademark a serial number of 98752632. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, March 24, 2025. This trademark is owned by Boehringer Ingelheim Pharmaceuticals, Inc.. The CARECONNECT4ME trademark is filed in the Insurance & Financial Services category with the following description:

Patient support, including providing information via a website to patients regarding insurance matters and payment options
careconnect4me

General Information


Serial Number98752632
Word MarkCARECONNECT4ME
Filing DateMonday, September 16, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, March 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkCARECONNECT FOR ME
Pseudo MarkCARECONNECT FOUR ME
Goods and ServicesPatient support, including providing information via a website to patients regarding insurance matters and payment options

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, September 16, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Trademark Events


Event DateEvent Description
Monday, September 16, 2024NEW APPLICATION ENTERED
Sunday, March 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 24, 2025ASSIGNED TO EXAMINER
Monday, March 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 24, 2025NON-FINAL ACTION WRITTEN
Monday, March 24, 2025NON-FINAL ACTION E-MAILED